Welcome to our dedicated page for Centene Del news (Ticker: CNC), a resource for investors and traders seeking the latest updates and insights on Centene Del stock.
Centene Corporation (NYSE: CNC) generates a steady flow of news related to government-sponsored healthcare programs, local health plans, and community health initiatives. As a Fortune 500 healthcare enterprise, Centene and its subsidiaries regularly issue updates on Medicaid and Medicare activities, Marketplace products, investor communications, and efforts to address social drivers of health such as food insecurity.
News items for Centene often feature announcements from local health plans that are companies of Centene Corporation. Examples include Health Net in California, Meridian Health Plan of Illinois, Ambetter Health Marketplace offerings, Coordinated Care in Washington, and specialty pharmacy activities from AcariaHealth. These stories cover topics such as value-based care partnerships, emergency assistance for members during natural disasters, public service announcements promoting preventive care, and investments in food banks and mobile pantry programs.
Investors and analysts following CNC can also find coverage of earnings-related events and financial communications. Centene files Form 8-K reports on quarterly results, updates to financial guidance, participation in healthcare conferences, and changes in board composition. These disclosures provide insight into the company’s financial outlook, use of non-GAAP measures, and governance developments.
For stakeholders interested in public health and community impact, Centene-related news highlights grants and collaborations with food banks, community organizations, and nutrition programs across multiple states. These initiatives illustrate how the enterprise and the Centene Foundation seek to improve access to nutritious food and support whole-person health. This news page brings together such corporate, financial, and community-focused updates for Centene Corporation and its affiliated health plans.
Health Net Federal Services, a subsidiary of Centene Corporation (CNC), announced its recent URAC accreditations in Health Utilization Management, Case Management, and Disease Management. This achievement underscores their commitment to quality care and improved patient outcomes. Health Net has maintained URAC's Health Utilization Management and Case Management accreditations since 2005, and Disease Management since 2011. These accreditations are valid through Dec. 1, 2023, for Health Utilization Management and Case Management, and through Oct. 1, 2023, for Disease Management.
Centene Corporation (CNC) and Magellan Health (MGLN) have announced a definitive merger agreement where Centene will acquire Magellan for $95 per share, totaling $2.2 billion. This strategic acquisition aims to enhance Centene's whole health capabilities and establish a leading behavioral health platform, expanding its reach to 41 million members and adding 5.5 million government-sponsored plan members. The transaction is expected to create shareholder value through improved services and synergies, with projected net cost synergies of $50 million by the second year.
Centene Corporation (NYSE: CNC) will present at the 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021, in a virtual format. The presentation will take place on January 11 at 9:10 a.m. EST. Interested parties can access a live audio webcast via this link. A replay of the webcast will be available on Centene's website under the Investors section. Centene is committed to providing high-quality healthcare services to underserved populations.
Centene Corporation (NYSE: CNC) has announced the completion of its acquisition of PANTHERx, a leading specialty pharmacy focused on orphan drugs and rare diseases. This strategic move enhances Centene's pharmacy portfolio and emphasizes its commitment to delivering quality care for patients with complex health needs. PANTHERx will continue to operate independently under Centene's Envolve Pharmacy Solutions, which provides integrated services to millions in the U.S. The acquisition aims to strengthen Centene's position in the healthcare market while broadening access to essential medications.
Centene Corporation (NYSE: CNC) announced its financial guidance for 2021, projecting total revenues between $114.1 billion and $116.1 billion. Diluted EPS is expected to range from $3.82 to $4.06, and adjusted diluted EPS is forecasted at $5.00 to $5.30. The health benefits ratio is anticipated to be between 86.6% and 87.2%, with SG&A expense ratios of 8.8% to 9.3%. The 2020 revenue guidance remains confirmed at $109.8 billion to $111.4 billion, while diluted EPS guidance is updated to $3.08 to $3.18.
Centene Corporation (NYSE: CNC) announced a definitive agreement to acquire PANTHERx, a leading specialty pharmacy focused on orphan drugs and rare diseases. The acquisition, subject to regulatory approval, is expected to close by the end of 2020. PANTHERx enhances Centene's pharmacy portfolio by providing specialized compliance, logistics, and analytics solutions for patients with rare diseases. The partnership aims to improve care delivery and access to medications for complex conditions, furthering Centene's commitment to underserved populations.
QualChoice Health Insurance appointed Chris O'Dwyer as the new Director of Sales, effective Nov. 23, 2020. With a 28-year career in health insurance, O'Dwyer brings extensive experience from both brokerage and carrier sides, most recently at CIGNA. His deep knowledge and community connections are expected to enhance QualChoice's customer support and market presence in Arkansas. O'Dwyer's commitment to helping businesses find the best insurance options aligns with the company's mission.
Centene Corporation (NYSE: CNC) has successfully completed its acquisition of Apixio, a healthcare analytics firm specializing in AI technology solutions. This strategic move aims to enhance Centene's healthcare administration and foster innovation. Apixio will operate independently within Centene's Health Care Enterprises group, focusing on delivering value to clients while benefiting from Centene's scale. Centene, a Fortune 50 company, serves numerous healthcare programs, emphasizing quality, cost-effectiveness, and long-term growth.
Centene Corporation (NYSE: CNC) has appointed Brent Layton as Executive Vice President, Markets, Products, International, and Chief Business Development Officer, effective January 1, 2021. Layton, a 20-year veteran at Centene, aims to enhance strategic alignment across key markets and products. He will succeed Kenneth Burdick, who will retire on January 23, 2021 but will continue as a consultant through the year. This leadership change is expected to strengthen the company's growth trajectory and service delivery.
Centene Corporation (NYSE: CNC) announced a hybrid format for its upcoming 2021 Financial Guidance and Investor Meeting on December 18, 2020, due to rising COVID-19 cases in Missouri. The meeting will include pre-recorded management presentations and live Q&A sessions, prioritizing health and safety while ensuring transparent communication with investors. Centene, a leading healthcare enterprise, serves nearly 1 in 15 individuals in the U.S. through various government-sponsored programs and healthcare services. Additional meeting details will be available on the company's investor relations website.